OLIGOCREATOR
Live / Applied — Non-final action mailed (as of 28 Oct 2025)
What this means for you
Not registered yet, but its 19 Mar 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79431050
- Mark type
- Stylized text
- Filed
- 19 Mar 2025
Goods and services
- Class 042 — Scientific and technological services: Scientific research services in the field of biochemistry [excluding the field of cell culture products], nucleic acids and bioinformatics, in particular molecular biology techniques, especially antisense techniques; design of pharmaceutical active ingredients by means of the aforementioned processes and techniques, including the use of bioinformatics techniques; development of pharmaceutical products by means of the aforementioned processes and techniques, including the use of bioinformatics techniques, including the performance of associated testing and diagnostic procedures; bioinformatic services for the pharmaceutical and biotechnological industry; services for evaluating the efficacy and safety of pharmaceutical products.
- Class 044 — Medical, beauty and agricultural services: Consultancy services to third parties in the field of biochemistry and nucleic acids and bioinformatics, including antisense technology, in relation to the development of pharmaceutical products; consultancy services to third parties in relation to the evaluation of safety and efficacy of pharmaceuticals.
- Class 045 — Legal and security services: Licensing of industrial property rights arising from the activities of a scientific research organisation in the field of biochemistry [excluding the field of cell culture products], nucleic acids and bioinformatics, in particular molecular biology working techniques, especially antisense technology as well as from the activities of designing active pharmaceutical ingredients by means of the aforementioned processes and techniques, including the use of bioinformatics techniques, from the development of pharmaceutical products by means of the aforementioned processes and techniques, including the use of bioinformatics techniques, including the performance of associated testing and diagnostic procedures, also from the information technology services for the pharmaceutical and biotechnological industry and from the services for evaluating the efficacy and safety of pharmaceutical products.
Owner
Prosecution history
- 15 Nov 2025 — REFUSAL PROCESSED BY IB
- 28 Oct 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 28 Oct 2025 — REFUSAL PROCESSED BY MPU
- 09 Sept 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 08 Sept 2025 — NON-FINAL ACTION WRITTEN
- 30 Aug 2025 — ASSIGNED TO EXAMINER
- 29 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 29 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 28 Aug 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB